Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A method for evaluation of brain tumor growth using implantable diffusion chambers.

J P Kapp, N A Moore, S A Roden

    Surgical Neurology
    |September 1, 1983
    PubMed
    Summary

    This study introduces a novel diffusion chamber assay for evaluating brain tumor chemotherapy sensitivity. The method offers a more accurate and cost-effective approach for drug screening in a living host environment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Wide variation and systematic bias in expert clinicians' perceptions of prognosis following brain injury.

    British journal of neurosurgery·2013
    Same author

    Is the 'A' in atypical really due to α2-adrenoceptor antagonism? A comment on: Putting the 'A' in atypical: does α2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    An internal shunt for use in the reconstruction of dural venous sinuses. Technical note.

    Journal of neurosurgery·2011
    Same author

    Management of pregnancy related carpal tunnel syndrome.

    Journal of the Mississippi State Medical Association·2000
    Same author

    The altered structure of renal papillary outflow tracts in obesity.

    Ultrastructural pathology·2000
    Same author

    Behavioural pharmacology of the new generation of antipsychotic agents.

    The British journal of psychiatry. Supplement·2000

    Area of Science:

    • Oncology
    • Pharmacology
    • Biotechnology

    Background:

    • In vitro chemotherapy sensitivity assays for brain tumors face limitations including endpoint validity issues, large tissue sample requirements, and high costs.
    • Existing assays do not account for in vivo drug metabolism or plasma protein binding, impacting therapeutic efficacy.
    • There is a need for a more reliable and physiologically relevant method to assess drug sensitivity in brain tumors.

    Purpose of the Study:

    • To develop and validate a diffusion chamber-based assay for quantifying brain tumor cell growth and chemosensitivity.
    • To provide a cost-effective and efficient method for screening chemotherapeutic agents against brain tumors under in vivo conditions.
    • To overcome the limitations of traditional in vitro assays by incorporating host physiological factors.

    Related Experiment Videos

    Main Methods:

    • Utilizing small-pore (0.22 micron) diffusion chambers to culture and protect tumor cells from host immune responses.
    • Implanting chambers containing quantified tumor cell inoculums into the peritoneal cavity of rats.
    • Quantifying tumor cell replication via enzymatic digestion and cell counting using hemocytometers or automated counters.

    Main Results:

    • The diffusion chamber assay allows for precise comparison of different chemotherapeutic drugs' effects on tumor cell growth in a host.
    • The method requires minimal tumor cells and basic cell culture laboratory equipment.
    • The assay enables the screening of novel chemotherapeutic agents against human tumors under physiological conditions.

    Conclusions:

    • The proposed diffusion chamber assay offers a promising alternative to conventional in vitro methods for brain tumor drug sensitivity testing.
    • This technique addresses key limitations of existing assays, providing more accurate and relevant data for therapeutic decisions.
    • The assay has the potential to be cost-effective and faster, facilitating the development of new cancer therapies.